Literature DB >> 16268926

Chronic pulmonary scedosporiosis simulating aspergillosis.

Takeharu Koga1, Takao Kitajima, Reiko Tanaka, Masashi Hirokawa, Masao Ichiki, Toru Rikimaru, Hisamichi Aizawa.   

Abstract

Scedosporium apiospermum, a ubiquitously distributed saprophyte, is emerging as an important pathogen in immunocompromised patients. We describe a 72-year-old patient with chronic S. apiospermum infection of the lung simulating aspergilloma. His medical history was unremarkable except that he had undergone partial lung resection as a treatment for pulmonary tuberculosis several decades previously. He had no underlying immunosuppressive conditions. This patient illustrates that pulmonary scedosporiosis is not confined to immunocompromised patients and that the clinical presentation may be indistinguishable from that of aspergilloma.

Entities:  

Mesh:

Year:  2005        PMID: 16268926     DOI: 10.1111/j.1440-1843.2005.00769.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

Review 1.  Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature.

Authors:  Fasih Ur Rahman; Muhammad Irfan; Naima Fasih; Kauser Jabeen; Hasanat Sharif
Journal:  Infection       Date:  2015-09-09       Impact factor: 3.553

2.  Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies.

Authors:  Christopher R Thornton
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

3.  SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY.

Authors:  Caroline T Nguyen; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

4.  Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis.

Authors:  Wei Liu; Rui-Zhi Feng; Hong-Li Jiang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

5.  Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.

Authors:  Tobias Lahmer; Marlena Messer; Ursula Ehmer; Stefan Eser; Analena Beitz; Lisa Fekecs; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2015-10-11       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.